proRITHM accelerates expansion across Southern India, eyes nationwide presence by early 2027

July 27, 2026 | Monday | News

Plans US entry in late 2027 or early 2028 while strengthening its portfolio with three granted patents

DeepFacts, a HealthTech startup behind proRITHM (an AI- and IoT-enabled Smart Remote Patient Monitoring platform), has announced its expansion roadmap, with plans to strengthen its presence across Andhra Pradesh, Karnataka, Tamil Nadu, and Odisha before expanding across India by early 2027.

It already holds a strong ground in Telangana. The company is also preparing for its entry into the US market by late 2027 or early 2028 as it continues to scale its AI-enabled healthcare solutions.

As part of its innovation journey, DeepFacts has secured three granted patents, reinforcing the company's focus on building proprietary healthcare technologies.

With a growing portfolio of intellectual property, expanding healthcare collaborations, and a clear roadmap for domestic and international growth, DeepFacts aims to accelerate the adoption of proRITHM, its AI-powered remote patient monitoring platform, while contributing to improved healthcare accessibility and outcomes.

Vamsi Karatam, Founder & CEO of DeepFacts said "The future of healthcare lies in continuous, intelligent monitoring that enables timely interventions rather than reactive treatment. Our focus is to make clinically reliable remote monitoring accessible to healthcare providers across India while building globally relevant technology. The next phase of our expansion is centred on strengthening our presence in key Indian markets, deepening collaborations with healthcare partners, and preparing for international expansion."

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

OR

Forgot your password?

OR

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy